Compass pathways stock forecast.

Oct 22, 2021 · And the biotechnology industry's average price-to-sales multiple is 4.7. Thus, if Compass manages to capture a mere 10% of that per year, it could be bringing in $139 million in revenue. Assuming ... *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. COMPASS Pathways Analyst Opinions. All. All ...18 ก.ย. 2563 ... Stock Forecast / Price Prediction / Prognosis: Compass Pathways Plc - ADR Forecast. Predictions, Comments & Questions.Based on short-term price targets offered by six analysts, the average price target for COMPASS Pathways PLC Sponsored ADR comes to $48.67. The forecasts range from a low of $19.00 to a high...Apr 26, 2021 · Shares of psychedelics-inspired medicine developer COMPASS Pathways (NASDAQ: CMPS) jumped more than 5% on Monday, continuing what has been a multi-day uptrend for CMPS stock.; CMPS stock is now up ...

Here are some of the best psychedelic sector stocks generating a buzz among investors: — Atai Life Sciences NV (ticker: ATAI) — GH Research PLC ( GHRS) — Compass Pathways PLC ( CMPS ...Compass Pathways jumped in its first day of trading on Friday, making it the first psychedelic drug company to go public on a big U.S. exchange.. X. Shares surged 70.6% to close at 29.00 in the ...The consensus 12-month price target for Compass Pathways reflects an upside potential of close to 325%. Even the most pessimistic analyst surveyed by Refinitiv thinks that the stock will double ...

Overall, the consensus among analysts is that Compass Pathways has a promising future ahead. CMPS Stock Analysis: Fluctuating Prices and Negative Earnings Growth, but Positive Forecast for the Future. On May 11, 2023, CMPS stock opened at the same price as the previous close, which was 8.59. Throughout the day, the stock’s price fluctuated ...

May 26, 2023 · COMPASS Pathways is looking at the long-term effects of COMP360 in our phase 3 programme in treatment-resistant depression.” Manish Agrawal, MD, Chief Executive Officer, Sunstone Therapies, and the trial’s Principal Investigator, said: “This pioneering study is the first of its kind, conducted within a community hospital cancer center. Cash position at 30 June 2022 of $207.2 million. Conference call today at 8:00am ET (1:00pm UK) COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to ...Stock Price Forecast The 11 analysts offering 12-month price forecasts for Doximity Inc have a median target of 25.00, with a high estimate of 31.00 and a low estimate of 21.00.COMPASS Pathways PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. CMPS updated stock price target summary. CMPS Stock Shows Strong Performance and Potential for Significant Growth in 2023. CMPS stock had a strong performance on November 3, 2023, based on the information provided. According to CNN Money, there are 9 analysts offering 12-month price forecasts for Compass Pathways PLC, with a median target of $33.00.

Compass Pathways has released the strongest evidence yet that psilocybin can improve outcomes in patients with treatment-resistant depression, linking its COMP360 candidate to a sharp improvement ...

Shares of psychedelics-inspired medicine developer COMPASS Pathways (NASDAQ: CMPS) jumped more than 5% on Monday, continuing what has been a multi-day uptrend for CMPS stock.; CMPS stock is now up ...

May 13, 2022 · COMPASS Pathways has a market cap of $299.3 million, and a 52-week range of $6.74 to $49.52. The stock has a price/book ratio of 1.32, and a price-to-free-cash-flow ratio of -6.9. May 6, 2023 · On May 2, COMPASS Pathways (CMPS 6.61%) announced that the American Medical Association (AMA) has given the green light for three new current procedural terminology (CPT) codes for psychedelic ... Real time Compass Pathways Plc (CMPS) stock price quote, stock graph, news & analysis.Based on short-term price targets offered by six analysts, the average price target for COMPASS Pathways PLC Sponsored ADR comes to $48.67. The forecasts range from a low of $19.00 to a high...2 de set. de 2022 ... ... stock could be Wall Street's biggest winner of the 2020s. Listen to the Podcast ➡️Spotify: https://open.spotify.com/show ...May 6, 2023 · On May 2, COMPASS Pathways (CMPS 6.61%) announced that the American Medical Association (AMA) has given the green light for three new current procedural terminology (CPT) codes for psychedelic ...

COMPASS Pathways ’s (CMPS) stock price is $6.1 and COMPASS Pathways ’s (CMPS) 100-day simple moving average is 7.59, creating a Sell signal. COMPASS Pathways ’s ( CMPS ) stock price is $6.1 and COMPASS Pathways ’s ( CMPS ) 200-day simple moving average is 8.13 , creating a Sell signal. A. While ratings are subjective and will change, the latest Compass Pathways ( CMPS) rating was a reiterated with a price target of $0.00 to $21.00. The current price Compass Pathways ( CMPS) is ...13 de mar. de 2023 ... Analysts at Canaccord Genuity (TSX:CF, LSE:CF) have reiterated their 'Buy' rating and US$60 price target for COMPASS Pathways after the ...The average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 1,490.91% from the current ATAI share price of $1.10. What is ATAI's forecast return on equity (ROE) for 2023-2026? (NASDAQ: ATAI) forecast ROE …5.01 Today ||| 52-Week Range 11.48 -26.03% Year-to-Date Quote Profile News Charts Forecasts Financials Shareholders Competitors vs. Health Technology News Chart Latest CMPS News | Press Releases...

A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at September 2021, COMPASS Pathways had cash of US$294m and no debt ...WebAtai bought another 619,095 Compass Pathways shares in recent days, taking its stake in the company from 19.4% to 20.8%. The new shares were bought at around $31 each, meaning Atai paid around $12 ...

On average, Wall Street analysts predict. that Compass Pathways's share price could reach $57.25 by Aug 22, 2024. The average Compass Pathways stock price prediction forecasts a potential upside of 857.36% from the current CMPS share price of $5.98. See COMPASS Pathways plc (CMPS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.2 de nov. de 2023 ... Each share of common stock and accompanying common warrant to purchase one share of common stock are being sold at a combined price to the ...While Compass Pathways' (CMPS 0.84%) stock is near $8, the analysts on Wall Street are figuring, on average, that its shares will explode by 458% to reach around $42.30 within the next 12 months.The Compass Pathways Plc ( CMPS) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $19.09, representing a …CMPS - Compass Pathways Plc - ADR Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Compass Pathways Plc ADR (CMPS) shares have gone down -22.59% during the last six months, with a year-to-date growth rate less than the industry average at -3.70% against 5.90. Yet analysts are ramping up their growth forecast for the fiscal year 2023. Revenue is predicted to grow 64.40% this quarter and then jump 7.00% in the …Web

Compass Pathways plc is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Compass Pathways plc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Compass Pathways plc or its management.

Low. $35.00. Average. $71.83. Current Price. $60.31. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...

Compass Pathways Plc ADR (CMPS) shares have gone down -22.59% during the last six months, with a year-to-date growth rate less than the industry average at -3.70% against 5.90. Yet analysts are ramping up their growth forecast for the fiscal year 2023. Revenue is predicted to grow 64.40% this quarter and then jump 7.00% in the …WebIn the same quarter last year, COMPASS Pathways's earnings per share (EPS) was -$0.44. COMPASS Pathways is expected to release next earnings on 02/26/2024, with ...Upgrade Your Account ... COMPASS Pathways plc NASDAQ: CMPS is a United Kingdom-based mental healthcare company developing psilocybin therapy through late-stage ...Psychedelics biotech giant COMPASS Pathways (NASDAQ: CMPS) has entered into a securities purchase agreement for an initial $125 million and potential additional of $160 million, with a select ...Aug 22, 2023 · COMPASS Pathways-stock; ... Compass Pathways has an average price target of $56.82 with a high of $120.00 and a low of $21.00. ... Some analysts will also offer forecasts for metrics like growth ... Current. -$0.61. 1 Month Ago. -$0.60. 3 Months Ago. -$0.65. COMPASS Pathways PLC ADR analyst estimates, including CMPS earnings per share estimates and analyst recommendations.Current. -$0.61. 1 Month Ago. -$0.60. 3 Months Ago. -$0.65. COMPASS Pathways PLC ADR analyst estimates, including CMPS earnings per share estimates and analyst recommendations.WebCOMPASS Pathways's market cap is currently ―. The company's EPS TTM is $-1.981; its P/E ratio is -2.86; COMPASS Pathways is scheduled to report earnings on March 4, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials. Dec 22. Sep 22.Latest CMPS News. View. COMPASS Pathways (CMPS, $5.98) entered Downtrend as Momentum indicator drops below 0 level on Nov 30, 2023. Tickeron - Stocks • 3 days ago. Compass Pathways to participate in upcoming Evercore investor conference. Globe Newswire • 10 days ago.CMPS Earnings Date and Information. COMPASS Pathways last posted its quarterly earnings data on November 2nd, 2023. The reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.50) by $0.17. COMPASS Pathways has generated ($2.59) earnings per share over the last year ( ($2.59) diluted …WebAnalyst Price Forecast Suggests 309.83% Upside. As of April 6, 2023, the average one-year price target for COMPASS Pathways Plc American Depository Shares is $42.38. The forecasts range from a low ...Web

COMP360 Overview (August Company Presentation) Psilocybin is a hallucinogenic chemical found in psychedelic mushrooms. It also is in Phase II clinical trials for the treatment of post-traumatic ...WebAbout the COMPASS Pathways Plc stock forecast. As of 2023 November 27, Monday current price of CMPS stock is 6.450$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Compass Pathways Plc - ADR stock price has been showing a declining tendency so we believe that similar market …WebAt close: 04:00PM EST. 6.06 0.00 (0.00%) After hours: 07:09PM EST. Find the latest COMPASS Pathways plc (CMPS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from ...Psychedelics biotech giant COMPASS Pathways (NASDAQ:CMPS) has entered into a securities purchase agreement for an initial $125 million and potential additional of $160 million, with a select group ...Instagram:https://instagram. what is the most valuable quartersbest annuities ratesearnings calendar apihydroponic weed growing COMPASS Pathways plc (CMPS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 5.93 -0.05 (-0.84%) At close: 04:00PM EST. 6.03 +0.10 (+1.69%) After hours: 07:53PM EST.47.29. -1.64%. 4.73M. Find the latest Compass Pathways Plc (CMPS) stock forecast, 12-month price target, predictions and analyst recommendations.Web oktastockrefinance rates chase According to 11 analyst offering 12-month price targets in the last 3 months, Compass Pathways has an average price target of $56.82 with a high of $120.00 and a low of $21.00.WebJul 1, 2023 · While Compass Pathways' (CMPS 0.84%) stock is near $8, the analysts on Wall Street are figuring, on average, that its shares will explode by 458% to reach around $42.30 within the next 12 months. goodyear tire and rubber co stock Compass Pathways jumped in its first day of trading on Friday, making it the first psychedelic drug company to go public on a big U.S. exchange.. X. Shares surged 70.6% to close at 29.00 in the ...The consensus 12-month price target for Compass Pathways reflects an upside potential of close to 325%. Even the most pessimistic analyst surveyed by Refinitiv thinks that the stock will double ...